Evidence map›Paper›PMID 30878612›Full record

Trial reportNeuroImage. Clinical2019

Non-pharmacological and pharmacological interventions relieve insomnia symptoms by modulating a shared network: A controlled longitudinal study.

Fen Feng, Siyi Yu, Zhengyan Wang, Jialin Wang, Joel Park, Georgia Wilson, Mou Deng, Youping Hu, Bohua Yan, Jian Kong

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in NeuroImage. Clinical, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Fen FengHospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Siyi YuDepartment of Acupuncture & Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China; Department of Psychiatry, Massachusetts General Hospital, Charlestown 02129, MA, USA.
Zhengyan WangSichuan Integrative Medicine Hospital, Chengdu 610041, China.
Jialin WangCollege of nursing, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Joel ParkDepartment of Psychiatry, Massachusetts General Hospital, Charlestown 02129, MA, USA.
Georgia WilsonDepartment of Psychiatry, Massachusetts General Hospital, Charlestown 02129, MA, USA.
Mou DengDepartment of mathematics and statistics, Sichuan Institute of Industrial Technology, Deyang 618005, Sichuan, China.
Youping HuDepartment of Acupuncture & Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Bohua YanHospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China. Electronic address: ybh612003@163.com.
Jian KongDepartment of Psychiatry, Massachusetts General Hospital, Charlestown 02129, MA, USA. Electronic address: kongj@nmr.mgh.harvard.edu.
Chengdu University of Traditional Chinese Medicine · CNMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary insomnia (PI) is one of the most common complaints among the general population. Both non-pharmacological and pharmacological therapies have proven effective in treating primary insomnia. However, the underlying mechanism of treatment remains unclear, and no studies have compared the underlying mechanisms of different treatments.

methodsIn this study, we investigated gray matter volume (GMV) and resting-state functional connectivity (rsFC) changes following both pharmacological and non-pharmacological treatments in patients with PI. A total of 67 PI patients were randomized into benzodiazepine treatment, cupping treatment, or a wait-list control group for 4 weeks. The Pittsburgh Sleep Quality Index (PSQI), gray matter volume (GMV), and resting-state functional connectivity (rsFC) of the hippocampus were measured at the beginning and end of the experiment.

resultsWe found 1) significantly decreased PSQI scores in the cupping and benzodiazepine treatment groups compared to the control group with no significant differences between the two treatment groups; 2) significant GMV increases in the cupping group compared to the control group at the right hippocampus after 4 weeks of treatment; 3) significantly increased rsFC between the right hippocampus and left rostral anterior cingulate cortex/medial prefrontal cortex (rACC/mPFC) in the two treatment groups, which was significantly associated with PSQI score decreases. DISCUSSION: Our findings suggest that benzodiazepine and cupping may share a common mechanism to relieve the symptoms of patients with PI.

Indexed as

Waiting ListsAdultBenzodiazepinesCupping TherapyFemaleGray MatterHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNerve NetSleep Initiation and Maintenance DisordersBenzodiazepinesGray matter volumeHippocampusNon-pharmacological therapyPharmacological therapyPrimary insomniaResting-state functional connectivity

Identifiers

PMID30878612
PMCPMC6423470
OpenAlexW2918723658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.